Expression of ERK1/2 MAPK signaling transduction pathway in esophageal cancers in Kazakh patients

Chinese Journal of Oncology

Volumn 33, Issue 6, 2011, Pages 421-425

  Zheng, Shu Tao ^a   Liu, Tao ^b   Tuersun, Aerziguli ^b   Huo, Qi ^b   Liu, Qing ^b   Huang, Cong Gai ^b   Feng, Jun Guo ^b   Lü, Guo Dong ^b   Wang, Xing ^b   Lin, Ren Yong ^b   Sheyhidin, Ilyar ^b   Lu, Xiao Mei ^b  

^a XINJIANG MEDICAL UNIVERSITY   (China)

^b NONE

Author keywords

Esophageal neoplasms; Extracellular signal related kinase mitogen activated protein kinase; Kazakh nationality

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3;

ARTICLE; CANCER CELL CULTURE; CARCINOMA IN SITU; ESOPHAGUS CARCINOMA; ESOPHAGUS MUCOSA; HUMAN; IMMUNOHISTOCHEMISTRY; INVASIVE CARCINOMA; KAZAKHSTAN; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SQUAMOUS CELL CARCINOMA; WESTERN BLOTTING;

BUTADIENES; CARCINOMA IN SITU; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CHINA; ENZYME INHIBITORS; ESOPHAGEAL NEOPLASMS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MAP KINASE SIGNALING SYSTEM; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; NITRILES; PHOSPHORYLATION; RNA, MESSENGER;

EID: 80053393570     PISSN: 02533766     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0253-3766.2011.06.005     Document Type: Article

References (10)

1. Balmannno K, Cook SJ. Tumor cell survival signaling by the ERK1/2 pathway. Cell Death Differ, 2009, 16:368-377.
2. Lawrence MC, Jivan A, Shao C, et al. The roles of MAPKs in disease. Cell Res, 2008, 18:436-442.
3. Lefloch R, Pouysségur J, Lenormand P. Single and combined silencing of ERK1 and ERK2 reveals their positive contribution to growth signaling depending on their expression levels. Mol Cell Biol, 2008, 28:511-527.
4. Roberts PJ, Der CJ. Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer. Oncogene, 2007, 26:3291-3310.
5. Lee HJ, Kim DI, Kang GH, et al. Phosphorylation of ERK1/2 and prognosis of clear cell renal cell carcinoma. Urology, 2009, 73:394-399.
6. Huynh H, Nguyen TT, Chow KH, et al. Over-expression of the mitogen-activated protein kinase (MAPK) kinase (MEK)-MAPK in hepatocellular carcinoma; its role in tumor progression and apoptosis. BMC Gastroenterol, 2003, 3:19.
7. Bang YJ, Kwon JH, Kang SH, et al. Increased MAPK activity and MKP-1 overexpression in human gastric adenocarcinoma. Biochem Biophys Res Commun, 1998, 250:4347.
8. Blackhall FH, Pintilie M, Michael M, et al. Expression and prognositc signficance of kit, protein kinase B, and mitogen-activated protein kinase in patients with small cell lung cancer. Clin Cancer Res, 2003, 9:2241-2247.
9. Garavello W, Nicolini G, Aguzzi A, et al. Selective reduction of extracellular signal-regulated protein kinase (ERK) phosphorylation in squamous cell carcinoma of the larynx. Oncol Rep, 2006, 16:479-484.